There is growing evidence that imaging biomarkers derived from multi-detector computed tomography (MDCT) and diffusion-weighted magnetic resonance imaging (DW-MRI) can be of great help in the diagnosis， monitoring of response to treatment and prognosis of gastric cancer.

评论发言